the Company agreed to sell to the Buyers 78,750 shares owned by the Company (the “Shares”) of Diagnosis S.A., a medical products producer and distributor headquartered in Białystok, Poland
For the fiscal years ended May 31, 2024, and 2023, the Company had one distributor each year that accounted for 33 % and 35 % of our net sales, respectively.
For the three months ended February 28, 2026, we had three key customers located in Asia, the Middle East, and the United States, which accounted for 50 % of net consolidated sales.
As of those dates, we had three and four key customers, respectively, located in Asia, the Middle East, the United States, and Europe, which accounted for 51 % and 69 % of gross accounts receivable, …
Biomerica, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
BMRA-DEBT
Debt stack $193,000
90%
Market cache reports total debt of $193,000.
Biomerica, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Biomerica, Inc..
Biomerica, Inc. Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for Biomerica, Inc..